Related Experiment Video
Updated: Jun 27, 2026
09:39
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
IL-13Rα2 Regulates C2C12 Myoblast Proliferation via the Akt-Cyclin D1-CDK4 Pathway
Mitsutoshi Kurosaka1, Kazuhisa Kohda1
1Department of Physiology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki 216-8511, Kanagawa, Japan.
International Journal of Molecular Sciences
|June 26, 2026
Summary
Interleukin-13 receptor α2 (IL-13Rα2) negatively regulates C2C12 myoblast proliferation via the Akt-Cyclin D1-CDK4 pathway. Its role in myoblast differentiation is negligible.
Area of Science:
- Cell Biology
- Molecular Biology
- Muscle Physiology
Background:
- Interleukin-13 receptor α2 (IL-13Rα2) is known as a decoy receptor.
- Its non-immune cellular functions, particularly in muscle cells, are not well understood.
Purpose of the Study:
- To investigate the role of IL-13Rα2 in the proliferation and differentiation of C2C12 myoblasts.
- To elucidate the signaling pathways involved in IL-13Rα2's function in myoblasts.
Main Methods:
- IL-13Rα2 knockdown in C2C12 cells using siRNA.
- Assessment of myoblast proliferation via BrdU incorporation and cell counting.
- Evaluation of myogenic differentiation through MyHC immunostaining and gene expression analysis.
- Analysis of signaling pathways (Akt, ERK) using immunoblotting and immunocytochemistry.
Main Results:
- IL-13Rα2 knockdown significantly increased C2C12 myoblast proliferation.
- Knockdown led to increased Akt phosphorylation and decreased ERK phosphorylation.
- Akt inhibition reversed the enhanced proliferation and normalized Cyclin D1/CDK4 levels.
- Myogenic differentiation and fusion-related gene expression remained unaffected by IL-13Rα2 knockdown.
Conclusions:
- IL-13Rα2 negatively regulates myoblast proliferation.
- The Akt-Cyclin D1-CDK4 signaling pathway mediates IL-13Rα2's effect on proliferation.
- IL-13Rα2 is dispensable for myogenic differentiation in C2C12 cells.
More Related Videos
13:15Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
Published on: February 25, 2016
12:19Stable Knockdown of Genes Encoding Extracellular Matrix Proteins in the C2C12 Myoblast Cell Line Using Small-Hairpin (sh)RNA
Published on: February 12, 2020
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
01:45Positive Regulator Molecules
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...